Studies of vitamin E in people
11 studies gave vitamin E to people and measured what changed
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on japanese knee osteoarthritis measure score no change: Has no effect on physical function down: Decreases inflammatory markers | Randomized trial24 weeks | 80 peopleWomen71.9 ± 5.6 yearsOlder adults; Postmenopausal women; Postmenopausal women with symptomatic knee osteoarthritis | Medicine, Oct 16, 2026 |
down: Decreases LDL-C | Randomized trial | 90 peopleGeneral population; in healthy volunteers | Nutrition, metabolism, and cardiovascular diseases : NMCD, Feb 25, 2025 |
down: Decreases hot flashesnearly one-third of the base amount, P = 0.002 down: Decreases triglycerideP < 0.001 down: Decreases aspartate aminotransferaseP = 0.007 | Randomized trialeight weeks | 84 peopleWomenPostmenopausal women | Health care for women international, Sep 2, 2022 |
down: Decreases CTX-0.003 ± 0.09 versus 0.121 ± 0.15 with placebo | Randomized trial12 weeks | 52 peopleWomenPostmenopausal women; Postmenopausal osteopenic women | Nutrients, Nov 25, 2021 |
down: Decreases hot flashesadjusted mean difference -8.7, 95% CI -0.6 to -15.0, P = 0.029 no change: Has no effect on anxietyP > 0.05 | Randomized trial8 weeks | 93 peopleWomen51.7 yearsPostmenopausal women; postmenopausal hot flashes | Complementary therapies in medicine, Nov 26, 2019 |
no change: Has no effect on fasting blood sugar | Randomized trial8 weeks | 86 peopleWomenPCOS | The Journal of clinical endocrinology and metabolism, Feb 1, 2019 |
no change: Has no effect on dementiaHR 0.88 (95% CI 0.64-1.20) | Randomized trialtrial from May 2002; cohort study September 2009 to May 2015 | 7,338 peopleMen60 years and olderOlder adults; Cox model adjusted for demographics and baseline comorbidities | JAMA neurology, Mar 21, 2017 |
no change: Has no effect on cognitive function no change: Has no effect on dementia11%/year no change: Has no effect on mortalityp = 0.086 | Randomized trial3 years | 337 peopleolder than 50 yearsOlder adults; Down syndrome | Neurology, May 4, 2016 |
no change: Has no effect on alanine aminotransferase26% vs 17% down: Decreases metabolic dysfunction-associated steatohepatitis58% vs 28% down: Decreases NAFLD Activity Scorechange in mean score, −1.8 vs −0.7 | Randomized trial96 weeks | 121 people81% malemean, 13.1 yearsChildren aged 8 to 17 years with NAFLD and persistently elevated levels of alanine aminotransferase | JAMA, Apr 27, 2011 |
up: Increases delayed-type hypersensitivity skin response65% increase versus 17% with placebo up: Increases hepatitis B antibody titer6-fold increase versus 3-fold with placebo up: Increases tetanus antibody titer | Randomized trial4 months | 88 peopleat least 65 yearsOlder adults; healthy elderly subjects | JAMA, May 7, 1997 |
| Randomized trial2 months | 20 peopleMen35–65 yearsMidlife adults; smokers | The American journal of clinical nutrition, Feb 1, 1997 |